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Abstract
The goal of functional genomics is to understand the relationship between whole genomes and phenotypes through a dynamic approach.
It requires high throughput technologies such as microarrays and data analysis. The power of this approach allowed to study complex biological functions as well as diseases. In this chapter, we introduce functional genomics and describe the statistical methods that are used to find differentially expressed genes. We analyze a large number of data sets produced on a complex disease, namely Down syndrome, in different models. We show that, whatever the model, genes that are in three copies are globally overexpressed. However, we failed to identify a set of two-copy genes that would be dysregulated in all studies. It either suggests that studies are incomplete, or that this set of genes does not exist and that overexpression of the three-copy genes impacts on the whole transcriptome in a "stochastic" way.
Introduction
Functional genomics has been or is being applied to complex diseases in the hope of finding molecular networks that are altered, as well as gene targets for treatment. The experiments were initiated as soon as tools were available, and this field of research has exploded with the commercialization of DNA microarrays and their relative affordability. Since the first development of DNA microarrays more than ten years ago (Schena et al, 1995) , the technology has improved in many aspects. Genome annotations are being updated and the probes associated to individual genes have been optimized for their selectivity and sensitivity. Although probe collections covering all the genes corresponding to various genomes are not fully optimized (Golfier et al, 2009 ) the data are improving and becoming consistent for powerful statistical analysis. The initial studies aiming at defining lists of differentially expressed genes have been disappointing and revealed that data analysis had to be extended using other tools than statistical tests. Many clustering methods and network analysis have been applied since. In parallel, gene ontology categorization has allowed a more functional view on the list of differentially ex- what are the functions of these genes, and if they belong to a particular network or pathway. Knowing this pathway will eventually give them the key for tuning it. Of course, the first question to ask is: has it been done, published and deposited in public databases (GEO www.ncbi.nlm.nih.gov/geo/ or Arrayexpress www.ebi.ac.uk/microarray-as/ae/)? If the answer is yes, there are data available on the subject; one should then plan to produce a different set of data, keeping in mind that this new set will need to be integrated with data sets available for the ultimate meta-analysis. It is just not possible to ignore other data sets since the power of analysis will be increased along with the size of samples. Then, of course, data need to be comparable, meaning preferably performed on the same type of microarray and possibly on the same platform. If not, then microarray annotation becomes a real issue that will h ave to be improved in the future. Isn't it surprising that with 497 398 samples (19 918 series) in GEO the number of meta-analyses is so low?
There are nowadays 44 datasets with 100 to 200 samples, 22 with 1 000 to 7 000 samples but none with more than 7 000 samples.
Alzheimer's disease (AD)
Let us take the example of AD, a neurodegenerative disease which affects 25 millions of individuals worldwide, and which is becoming a real societal problem. Many gene profiling studies have been performed on AD patient samples (brain, peripheral cells) but no coher-ent picture of gene expression regulation in AD was obtained (Maes et al, 2007) (Nagasaka et al, 2005 ) (Blalock et al, 2004 ) (Emilsson et al, 2006 ) (Lu et al, 2004 Such analyses are still under development and will bring answers to this major problem (Bontoux et al, 2008) . It might be though that the control of cellular function has both deterministic and stochastic elements: complex regulatory networks define stable states that drive individual cells, whereas stochastic fluctuations in gene expression ensure transitions and coherence at the population level (Macarthur et al, 2009) . Stochastic "noise" arises from random fluctuations within the cell and is an unavoidable aspect of life at the single-cell level. Evidence is accumulating that this noise crucially influences cellular auto-regulatory circuits and can "flip" genetic switches to drive probabilistic fate decisions (Singh and Weinberger, 2009 ). Stochastic noise in gene expression propagates through active, but not inactive, regulatory links and it was recently shown that extrinsic noise sources generate correlations even without direct regulatory links (Dunlop et al, 2008) . In bacteria, it was shown that noise in expression of specific genes selects cells for competence, and experimental reduction of this noise decreases the number of competent cells (Maamar et al, 2007) . This stochastic noise could have an impact on cell fate either during development but also during disease progression. It is assumed that during development, cells acquire their fate by virtue of their lineage or their proximity to an inductive signal from another cell. However, cells can choose one or another pathway of differentiation stochastically, without apparent regard to environment or history, and this stochastic character could be critical for the maintenance of species (Losick and Desplan, 2008) . Although these aspects have been studied in bacteria and yeasts, it is still particularly difficult to explore in multicellular organisms and in diseases.
The experimental design applied to complex human diseases has focused on gene expression regulation in tissues or cultured cells, thus excluding the single cell resolution. Although stochastic gene expression was mentioned, it is not possible to differentiate single cell level noise from tissue complexity, cellular heterogeneity and interindividual variability.
Recently, with the use of systems biology approaches, two studies have revealed new interesting molecular networks related to AD.
The first study applied weighted gene coexpression network analysis (WGCNA) to microarray datasets analyzing brain samples (the CA1 region of the hippocampus) from AD patients and comparing to brain samples (frontal lobe) from normal elderly people (Miller et al, 2008) . This analysis produced modules of co expressed genes that are functionally related with some relevant to disease progression and others conserved between AD and normal aging. In the second study, gene profiling of laser microdissected samples from the en-torhinal cortex were analyzed slightly differently. Modules of highly correlated genes were constructed and among these genes regulatory cis elements were identified. New links have been identified between cardiovascular diseases, AD and diabetes (Ray et al, 2008) .
Genome wide association studies (GWAS) have recently revealed the power of analyzing a very large number of samples (>1000) (Harold et al, 2009; Lambert et al, 2009) . Although getting genomic DNA samples is far much easier than getting brain samples, one would imagine that larger sample gene profiling datasets with less heterogeneous samples will improve the readout of the analysis.
Down syndrome (DS)
We have been interested in another complex disease, namely Down Amano et al, 2004; Dauphinot et al, 2005; FitzPatrick et al, 2002; Giannone et al, 2004; Lockstone et al, 2007; Mao et al, 2005; Mao et al, 2003; Potier et al, 2006; Saran et al, 2003) . However, even if the mean over-expression we and others reported to be close to the expected value of 1.5, recent studies in DS cell lines have reported that about 70% of the three-copy genes were signicantly below the 1.5 ratio.
In these particular cell lines at least, a large proportion of the chromosome 21 transcripts were compensated for the primary gene dosage effect (Ait Yahya-Graison et al, 2007; Prandini et al, 2007) .
As for non-chromosome 21 genes, results are less consistent. The aneuploidy of an entire chromosome could affect the expression of either a limited number of genes, or a large number in a more random and extensive way (Mao et al, 2005; Saran et al, 2003) . Conversely classification of samples on the basis of their whole transcriptome has not been applied systematically in the published gene expression studies of DS. Rather it was unfortunately wrongly applied such as in Slonim et al. (Slonim et al, 2009) . In this study they conclude to a widespread differential expression between trisomic and euploid samples based on clustering of genes differentially expressed between trisomic and euploid, excluding the chromosome 21
genes. It seems obvious that differentially expressed genes between two conditions would be able to differentiate the two conditions.
Nevertheless this question regarding the regulation of gene expression for non-chromosome 21 genes is still debated, and more com-prehensive studies assessing the variability among samples, tissues and development stages are needed.
We have designed several large scale gene expression studies in which we could measure the effects of trisomy 21 on a large number of samples in tissues or cells that are affected in DS (Dauphinot et al, 2005; Laffaire et al, 2009; Moldrich et al, 2009 ). All were performed with the Ts1Cje mouse model of DS which is a segmental trisomy of mouse chromosome 16 (MMU16) with many genes orthologous to human chromosome 21 (HSA21) present in three copies (about 95). This mouse model has the advantage of being available as large colonies of mice on B6C3SnF1/Orl mixed genetic background and rapidly screened (Sago et al, 2000) . Experiments were designed in order to correlate gene expression changes with the phenotype observed. Two data sets focused on cerebellum since adult Ts1Cje mice show a reduction in cerebellar volume that parallel the observations in DS patients and in another mouse model of DS (Ts65Dn mice) (Baxter et al, 2000; Olson et al, 2004) . The reduced size of the cerebellum and the reduced cerebellar granule cell number in Ts65Dn adults originate around birth because of a defect in granule cell precursor proliferation (Roper et al, 2006) . In our studies, three early postnatal time points that are crucial for cerebellar development were investigated which could provide a read-out of genes involved in cerebellar hypoplasia in DS. These three time points correspond to birth (P0) and postnatal days 15 (P15) and 30 (P30). During the P0-P10 time period granule cells proliferate and migrate from the external to the internal granule cell layer and Purk-inje cells start differentiating and growing their highly dense dendritic tree. We quantied the proliferation of granule cell precursors on xed cerebellum slices of Ts1Cje and euploid mice at P0, P3 and P7 using immunohistochemistry and histology. A signicant 30%
decrease of their mitotic index was observed at P0 but not at P3 and P7, in agreement with the results obtained in Ts65Dn mice (Roper et al, 2006) . Finally and in order to nd gene expression variations in cerebellar regions rich in granule cell precursors, external granule cell layers of newborn Ts1Cje and euploid mice were dissected and analyzed on microarrays.
We also integrated data sets that contained a number of samples that was sufficient for statistical analysis (n 4). These included the studies of Saran et al. from 2003 (Mao et al, 2003; Saran et al, 2003) . The first dataset contains gene expression profiles of human fetal cortex and cultured astrocytes from 4 Down syndrome cases and 4 controls. The second study produced gene expression profiles of the adult cerebellum from the Down syndrome mouse model Ts65Dn.
We included in the meta analysis the data set from Amano et al. 2004 from whole brain of newborn Ts1Cje mice (Amano et al, 2004) , the one from 2007 of Lockstone et al. (Lockstone et al, 2007) and (Slonim et al, 2009) . Indeed, from all the samples published, less than 1000 genes were expressed in all experiments, which were not representative enough for the analysis to be meaningful.
Elements of microarray statistical analysis
The aim of this section is not to propose an exhaustive panorama of the existing methods for the analysis of microarray data, but rather to give the necessary and sufficient technical elements needed in order to understand and to reproduce the statistical treatments that we or the authors we cite have applied to the various data sets surveyed in this chapter.
Data normalization
In addition to the variability of interest that is due to the difference between diseased (here DS) and normal tissue, observed expression levels are also subject to the variability introduced during sample preparation, the manufacture and the processing of the arrays (labeling, hybridization and scan). Even if some of this unwanted variability can be controlled using appropriate experimental design and procedures, for example by having all experiments performed at a single time point by a single operator, some of it can not be controlled, but still needs to be corrected. The most famous of these sources is perhaps the dye bias for cDNA microarray experiments, where the efficiency, heat and light sensitivities differ for Cy3 and Cy5, resulting in a systematically lower signal for Cy3. For cDNA microarrays, the normalization procedure proposed in (Dudoit S, 2002 ) was shown to be efficient. It is based on Cleveland's robust locally weighted regression for smoothing scatterplots (Cleveland, 1979) , and consists in fitting a lowess curve to the MA plot of log intensities 1 of the red and green labels and considering the residuals as the normalized log ratios.
This approach is not directly applicable to single color arrays, such as the Affymetrix or Illumina arrays considered in this chapter.
However, contrarily to the current perception that the lowess normalization is only suited for normalizing two single color arrays at a time, (Sasik CH, 2004) showed that lowess can indeed be applied across n > 2 arrays, assuming that most genes expressions do not change notably across the n experiments.
In practice, multiple lowess proves quite similar to quantile normalization, which is a much lighter procedure. The principle of quantile normalization is to make the distribution of the probe intensities equal to a reference distribution for each of the n arrays. This reference distribution is the mean distribution of the n arrays, computed by sorting all p probe intensities of each array in increasing order, and computing the i th reference intensity value as the mean of the i th intensity values of the n arrays. Boldstad et al. showed the efficiency of the method, which is commonly used for the normalization of Affymetrix data (Bolstad et al, 2003) .
Let us illustrate this efficiency with an example exhibiting a known undesirable effect. Gene expression was measured twice on cell lines from 12 DS patients at a two month interval on Illumina chips with 48 701 probes, the labeling being the same for the two hybridizations. Figure 1a shows the raw intensity values for the 24 arrays, those of the first hybridization in black, those of the second in grey:
the two groups differ visibly. One also notices differences among the first and second hybridization, the arrays being located on two different Illumina chips (there were up to 6 arrays on the considered Illumina chips). Figure 1b shows the mean distribution used for quantile normalization. This illustration using PCA leads us to the second part of the analysis, that of data visualization prior to differential analysis.
Dimensionality reduction and data visualization
The result of a microarray experiment involving n arrays with p probes presents itself as a nxp matrix of -now normalized -intensi-ties, which can be viewed as the representation of n tissues by the intensities of their p genes or probes (typically hundreds or thousands), or conversely, as the representation of the p probes by their expression in n tissues (typically tens or even less). In this chapter, we will focus on the first view, which raises the problem of visualizing ob- A second goal may be to exhibit groups of tissues, especially according to the known differences between them, such as normal and DS tissues. In this context, we must insist that PCA is an unsupervised procedure, whose only property is that the projection in the ddimension space generated by the d first principal axes has the highest variance among all possible projections in a d-dimension space.
The direction of maximum variance being composed of variance within the groups and variance between the groups, the first principal components need not necessarily reflect the direction in the probe space that is best for revealing the group structure of the tissues. 
Differential analysis at the gene level
The purpose of differential analysis at the gene (or transcript) level is to identify genes whose expression level differs from a condition to another, based on statistical hypothesis testing. Almost all experiments analyzed in this chapter involve two groups of tissues, normal and DS tissues, usually unpaired. Thus, the traditional t-test is relevant for our purpose, which reformulates the question of differential expression of gene i in terms of a null hypothesis H 0i
"there is no difference of mean expression for the transcript i between the normal and the DS tissues". Student's t-test is indeed the test that was used in almost all reviewed papers, and that we used for the experiments for which no analysis was published. Once the tstatistic is computed, the classical decision rule to accept or reject H 0i consisting in controlling the type I error probability can be applied for declaring each gene differentially expressed (DE) or not.
However, the specificity of microarray differential analysis lies in the large number of tests to be performed: as many as probes on the array, or at least, as expressed transcripts. The question of differential expression must hence be restated as a multiple testing problem.
The first attempts to solve this problem aimed at controlling the Here, the smallest q-value equals 0.26, one cannot impose the FDR to be smaller than 26% (627 transcripts are DE with a FDR of 26%).
Thus, in the situations where the assumptions that the data is normal and/or that the variances are unequal are really unsuitable, the best alternative is to estimate the empirical distribution of the t-statistics using permutation methods such as bootstrap or permutations, see Westfall & Young (SS, 1992) . A particularly popular and efficient permutation method is the Significance Analysis of Microarrays (SAM) proposed by Tusher et al. (Tusher et al, 2001 ).
Differential analysis at the gene set level
In order to take full advantage of the differential analysis at the gene level, which merely provides an unstructured list of DE genes, an integration at a higher level is necessary. Thus, the identification of predefined sets of biologically related genes enriched or depleted with DE genes has become a routine part of the analysis and of the interpretation of microarray data.
Gene sets can be built on several criteria. These criteria can be based on the available annotation sources such as GO, the Gene Ontology project, KEGG , the Kyoto Encyclopedia of Genes and Genomes, or The p-values of the hypergeometric test and of LRpath are shown in Gene set enrichment analysis (GSEA), in the version proposed by Subramanian et al. (Subramanian et al, 2005) , is used for example in Slonim et al. (Slonim et al, 2009) Finally, let us mention ProbeCD, the method proposed by Vencio & Schmulevitch (Vencio and Shmulevich, 2007) . ProbCD not only presents the advantage of not requiring the choice of a significance cutoff, but it is also able to take the uncertainty in the gene annotation into account. Table 1 .2 summarizes the data sets considered in this study. As detailed in the previous section, PCA was applied to the normalized datasets, on the transcripts expressed across all arrays. Three different PCA were systematically performed: one with all expressed transcripts, another with the expressed three-copy transcripts only (those of HSA21 or of the triplicated part of MMU16), and the last with the remaining euploid transcripts. The ultimate goal of this analysis was to visualize whether samples would be grouped according to their genotype (DS or control) and in which conditions (with all genes, with triplicated genes only and/or with the euploid genes only). From the analysis including the three copy genes only, samples from DS models are very clearly separated from samples from euploid controls. This is due to the global overexpression of the three copy genes that has been largely described previously. Indeed, in DS, three-copy genes are globally over-expressed by a mean factor of 1.5. However at the single gene resolution, this 1.5 overexpression does not strictly apply and several comprehensive studies have shown that compensation and amplification mechanisms do exist.
Results
Compensated three-copy genes will not be over-expressed while amplified three-copy genes will be over-expressed by a factor significantly higher than 1.5 (Ait Yahya-Graison et al, 2007; Prandini et al, 2007) . For the datasets with a clear separation, we tested the influence of the three-copy genes. We removed them and run the PCA on all expressed genes except the three-copy genes. The right panels of Figure 1 .14, it is clear that the impact of development on gene expression is much bigger than the impact of trisomy 21, as was discussed previously (Dauphinot et al, 2005) .
In the case of the data set from Amano et al., again whole brains were obtained at birth with possibly an up to 24hours difference between litters and even between pups. It is known that the embryos from a litter are not totally equivalent in term of development depending on their position in the uterus. Figure 1 .8 PCA of the data described in Lockstone et al. (Lockstone et al, 2007) . Figure 1 .9 PCA of the data described in Pevsner (GEO GSE9762). Figure 1 .10 PCA of the data described in Saran et al. (Saran et al, 2003) . Figure 1 .11 PCA of the data described in Mao et al. (Mao et al, 2003) . Figure 1 .12 PCA of the data described in Amano et al. (Amano et al, 2004) . Figure 1 .13 PCA of the data described in Laffaire et al. (Laffaire et al, 2009 ). The three markers correspond to three different litters. Figure 1 .14 P C A o f the data described in Dauphinot et al. (Dauphinot et al, 2005) . The three markers correspond to three different developmental stages (P0, P15, P30).
Conclusion
Functional genomics needs to be applied to complex diseases. In the case of Down syndrome, we have used gene expression profiling in various human samples or in mouse models and shown that, when we selected the three-copy genes for the analysis, samples were separated according to their genotype (DS or euploid) in all data sets. This is due to the global over-expression of the three-copy genes in DS or in mouse models. When using all expressed genes, samples were separated according to their genotype only in some datasets. This suggests that, in the datasets with no separation, there is a factor other than trisomy that strongly impacts on the transcriptome. We have shown that this factor can be the postnatal development of the cerebellum.
It now remains to be shown whether, beside the global overexpression of the three-copy genes, there will be a common set of genes that is modified in all samples analyzed. We and others have tried to search for this group of genes without any frank success. To get a more precise answer, very large sets of data will need to be generated, or alternatively, gene profiling should be obtained from not exist, it suggests that the most important trend is the overexpression of the three-copy genes themselves that secondarily impacts on the whole transcriptome in a "stochastic" way.
